More articles from TRANSLATING IMMUNOLOGY

You have accessRestricted access
Translating JAKs to Jakinibs
Massimo Gadina, Danielle A. Chisolm, Rachael L. Philips, Iain B. McInness, Paul S. Changelian and John J. O’Shea

J Immunol 204 (8) 2011-2020; April 15, 2020, doi: https://doi.org/10.4049/jimmunol.1901477
You have accessRestricted access
A 20-Year Journey from Axonal Injury to Neurodegenerative Diseases and the Prospect of Immunotherapy for Combating Alzheimer’s Disease
Michal Schwartz, Javier M. Peralta Ramos and Hila Ben-Yehuda

J Immunol 204 (2) 243-250; January 15, 2020, doi: https://doi.org/10.4049/jimmunol.1900844
You have accessRestricted access
Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases
Maryam Tahvildari and Reza Dana

J Immunol 203 (11) 2749-2755; December 1, 2019, doi: https://doi.org/10.4049/jimmunol.1900733
You have accessRestricted access
T Cell–Activating Bispecific Antibodies in Cancer Therapy
Asaad Trabolsi, Artavazd Arumov and Jonathan H. Schatz

J Immunol 203 (3) 585-592; August 1, 2019, doi: https://doi.org/10.4049/jimmunol.1900496
You have accessRestricted access
Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
Jason E. Hawkes, Bernice Y. Yan, Tom C. Chan and James G. Krueger

J Immunol 201 (6) 1605-1613; September 15, 2018, doi: https://doi.org/10.4049/jimmunol.1800013
You have accessRestricted access
Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies
Cristina João, Vir Singh Negi, Michel D. Kazatchkine, Jagadeesh Bayry and Srini V. Kaveri

J Immunol 200 (6) 1957-1963; March 15, 2018, doi: https://doi.org/10.4049/jimmunol.1701271
You have accessRestricted access
Inhibitors of the PD-1 Pathway in Tumor Therapy
Martin W. LaFleur, Yuki Muroyama, Charles G. Drake and Arlene H. Sharpe

J Immunol 200 (2) 375-383; January 15, 2018, doi: https://doi.org/10.4049/jimmunol.1701044
You have accessRestricted access
Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology
Afsaneh Shirani and Olaf Stüve

J Immunol 198 (4) 1381-1386; February 15, 2017, doi: https://doi.org/10.4049/jimmunol.1601358
You have accessRestricted access
From IgE to Omalizumab
Toshiaki Kawakami and Ulrich Blank

J Immunol 197 (11) 4187-4192; December 1, 2016, doi: https://doi.org/10.4049/jimmunol.1601476
You have accessRestricted access
Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway
Andrew B. Adams, Mandy L. Ford and Christian P. Larsen

J Immunol 197 (6) 2045-2050; September 15, 2016, doi: https://doi.org/10.4049/jimmunol.1601135

Main menu

User menu

Search

More articles from TRANSLATING IMMUNOLOGY

Pages

Navigate

For Authors

General Information

Journal Services